Insulin protein
Katalog-Nummer MBS537118-5x25mg
Size : 5x25mg
Marke : MyBiosource
Insulin (INS) Active Protein
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS537118MBS537118 is an active protein targeting INS. Also known as Insulin protein. Host: Human. Purified recombinant Human Insulin protein More details
Product Overview
Online Datasheet in PDFProduct Name
Insulin, Active Protein
Full Product Name
Insulin protein
Product Gene Name
INS active protein
Product Synonym Names
Insulin recombinant protein
Host
Human
Form/Format
Lyophilized powder. Insulin is not soluble at neutral pH. It can be solubilized (1 - 10 mg/mL) in dilute acetic acid or dilute hydrochloric acid, pH 2-3.
Purity/Purification
> 99% pure
Preparation and Storage
Store at 4 degree C until reconstitution. Following reconstitution aliquot and freeze at -20 degree C for long term storage. Avoid repeated freeze-thaw cycles.
Molecular Weight
21,537 Da
OMIM
125852
Active Protein Note
Protein activity can be an ambiguous term. Please refer to the data sheet or inquire with Technical Support to determine the definition of activity for this product.
Protein Type
Recombinant
Bioactivity
28 I.U. per mg. 1 unit corresponds to the efficiency of 0.04167 mg international standard substance.
Expression System
E Coli
Product Categories/Family for INS active protein
Hormones & Steroids
Other Notes
Small volumes of INS active protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for INS. It may not necessarily be applicable to this product.
NCBI Official Full Name
insulin
NCBI Official Synonym Full Names
insulin
NCBI Official Symbol
INS
NCBI Official Synonym Symbols
IDDM; ILPR; IRDN; IDDM1; IDDM2; MODY10
UniProt Protein Name
Insulin
Protein Family
Insulin
UniProt Gene Name
INS
UniProt Entry Name
INS_HUMAN
NCBI Protein Information
insulin
NCBI Summary for INS
After removal of the precursor signal peptide, proinsulin is post-translationally cleaved into three peptides: the B chain and A chain peptides, which are covalently linked via two disulfide bonds to form insulin, and C-peptide. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. A multitude of mutant alleles with phenotypic effects have been identified. There is a read-through gene, INS-IGF2, which overlaps with this gene at the 5' region and with the IGF2 gene at the 3' region. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2010]
Show more UniProt Comments for INS
Insulin: Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. Heterodimer of a B chain and an A chain linked by two disulfide bonds. Belongs to the insulin family.
Protein type: Secreted; Secreted, signal peptide; Hormone
Chromosomal Location of Human Ortholog: 11p15.5
Cellular Component: extracellular space; Golgi lumen; endoplasmic reticulum lumen; extracellular region
Molecular Function: insulin-like growth factor receptor binding; identical protein binding; protein binding; protease binding; hormone activity; insulin receptor binding
Biological Process: positive regulation of nitric oxide biosynthetic process; positive regulation of vasodilation; glucose homeostasis; activation of NF-kappaB transcription factor; negative regulation of protein oligomerization; positive regulation of glucose import; regulation of protein localization; cell-cell signaling; negative regulation of gluconeogenesis; acute-phase response; regulation of transmembrane transporter activity; negative regulation of NAD(P)H oxidase activity; positive regulation of mitosis; activation of protein kinase B; positive regulation of nitric-oxide synthase activity; negative regulation of acute inflammatory response; glucose metabolic process; positive regulation of lipid biosynthetic process; positive regulation of cell growth; positive regulation of protein amino acid autophosphorylation; positive regulation of phosphoinositide 3-kinase cascade; positive regulation of peptidyl-tyrosine phosphorylation; negative regulation of protein catabolic process; regulation of amino acid metabolic process; positive regulation of cell differentiation; negative regulation of glycogen catabolic process; wound healing; positive regulation of glycogen biosynthetic process; positive regulation of cellular protein metabolic process; glucose transport; regulation of protein secretion; regulation of transcription, DNA-dependent; positive regulation of MAPKKK cascade; negative regulation of vasodilation; negative regulation of lipid catabolic process; positive regulation of cell proliferation; negative regulation of proteolysis; negative regulation of protein secretion; MAPKKK cascade; negative regulation of fatty acid metabolic process; alpha-beta T cell activation; endocrine pancreas development; positive regulation of protein kinase B signaling cascade; G-protein coupled receptor protein signaling pathway; cellular protein metabolic process; fatty acid homeostasis; positive regulation of glycolysis; insulin receptor signaling pathway; energy reserve metabolic process; positive regulation of insulin receptor signaling pathway; regulation of insulin secretion; positive regulation of DNA replication; positive regulation of cell migration; positive regulation of cytokine secretion
Disease: Diabetes Mellitus, Insulin-dependent, 2; Diabetes Mellitus, Permanent Neonatal; Hyperproinsulinemia; Maturity-onset Diabetes Of The Young, Type 10
Show more Protein type: Secreted; Secreted, signal peptide; Hormone
Chromosomal Location of Human Ortholog: 11p15.5
Cellular Component: extracellular space; Golgi lumen; endoplasmic reticulum lumen; extracellular region
Molecular Function: insulin-like growth factor receptor binding; identical protein binding; protein binding; protease binding; hormone activity; insulin receptor binding
Biological Process: positive regulation of nitric oxide biosynthetic process; positive regulation of vasodilation; glucose homeostasis; activation of NF-kappaB transcription factor; negative regulation of protein oligomerization; positive regulation of glucose import; regulation of protein localization; cell-cell signaling; negative regulation of gluconeogenesis; acute-phase response; regulation of transmembrane transporter activity; negative regulation of NAD(P)H oxidase activity; positive regulation of mitosis; activation of protein kinase B; positive regulation of nitric-oxide synthase activity; negative regulation of acute inflammatory response; glucose metabolic process; positive regulation of lipid biosynthetic process; positive regulation of cell growth; positive regulation of protein amino acid autophosphorylation; positive regulation of phosphoinositide 3-kinase cascade; positive regulation of peptidyl-tyrosine phosphorylation; negative regulation of protein catabolic process; regulation of amino acid metabolic process; positive regulation of cell differentiation; negative regulation of glycogen catabolic process; wound healing; positive regulation of glycogen biosynthetic process; positive regulation of cellular protein metabolic process; glucose transport; regulation of protein secretion; regulation of transcription, DNA-dependent; positive regulation of MAPKKK cascade; negative regulation of vasodilation; negative regulation of lipid catabolic process; positive regulation of cell proliferation; negative regulation of proteolysis; negative regulation of protein secretion; MAPKKK cascade; negative regulation of fatty acid metabolic process; alpha-beta T cell activation; endocrine pancreas development; positive regulation of protein kinase B signaling cascade; G-protein coupled receptor protein signaling pathway; cellular protein metabolic process; fatty acid homeostasis; positive regulation of glycolysis; insulin receptor signaling pathway; energy reserve metabolic process; positive regulation of insulin receptor signaling pathway; regulation of insulin secretion; positive regulation of DNA replication; positive regulation of cell migration; positive regulation of cytokine secretion
Disease: Diabetes Mellitus, Insulin-dependent, 2; Diabetes Mellitus, Permanent Neonatal; Hyperproinsulinemia; Maturity-onset Diabetes Of The Young, Type 10
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with INS active protein
| Reference Product | PubMed Publications |
|---|---|
| PDX1 active protein | >61 publications with INS and PDX1 |
| IRS1 active protein | >38 publications with INS and IRS1 |
| FOXO1 active protein | >35 publications with INS and FOXO1 |
| INSR active protein | >33 publications with INS and INSR |
| IRS2 active protein | >30 publications with INS and IRS2 |
| IGF1R active protein | >24 publications with INS and IGF1R |
| AKT1 active protein | >18 publications with INS and AKT1 |
| IGFBP1 active protein | >8 publications with INS and IGFBP1 |
Pathways associated with INS active protein
| Products by Pathway | Pathway Diagram |
|---|---|
| AGE/RAGE Pathway antibodies | AGE/RAGE Pathway Diagram |
| AMPK Signaling Pathway antibodies | AMPK Signaling Pathway Diagram |
| AMPK Signaling Pathway antibodies | AMPK Signaling Pathway Diagram |
| ATF-2 Transcription Factor Network Pathway antibodies | ATF-2 Transcription Factor Network Pathway Diagram |
| Adipogenesis Pathway antibodies | Adipogenesis Pathway Diagram |
| Aldosterone-regulated Sodium Reabsorption Pathway antibodies | Aldosterone-regulated Sodium Reabsorption Pathway Diagram |
| Aldosterone-regulated Sodium Reabsorption Pathway antibodies | Aldosterone-regulated Sodium Reabsorption Pathway Diagram |
| Amyloids Pathway antibodies | Amyloids Pathway Diagram |
| Arf6 Trafficking Events Pathway antibodies | Arf6 Trafficking Events Pathway Diagram |
| Cardiac Progenitor Differentiation Pathway antibodies | Cardiac Progenitor Differentiation Pathway Diagram |
Diseases associated with INS active protein
| Disease Name | Pubmed Publications |
|---|---|
| Metabolic Diseases Antibodies | >1163 publications with INS and Metabolic Diseases |
| Diabetes Mellitus Antibodies | >969 publications with INS and Diabetes Mellitus |
| Insulin Resistance Antibodies | >346 publications with INS and Insulin Resistance |
| Diabetes Mellitus, Type 2 Antibodies | >332 publications with INS and Diabetes Mellitus, Type 2 |
| Obesity Antibodies | >261 publications with INS and Obesity |
| Hyperglycemia Antibodies | >237 publications with INS and Hyperglycemia |
| Hyperinsulinism Antibodies | >225 publications with INS and Hyperinsulinism |
| Hypertension Antibodies | >135 publications with INS and Hypertension |
| Polycystic Ovary Syndrome Antibodies | >60 publications with INS and Polycystic Ovary Syndrome |
| Hypoglycemia Antibodies | >53 publications with INS and Hypoglycemia |
Organs/Tissues associated with INS active protein
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Pancreas Antibodies | >1632 publications with INS and Pancreas |
| Blood Antibodies | >1602 publications with INS and Blood |
| Brain Antibodies | >821 publications with INS and Brain |
| Muscle Antibodies | >577 publications with INS and Muscle |
| Liver Antibodies | >429 publications with INS and Liver |
| Heart Antibodies | >316 publications with INS and Heart |
| Kidney Antibodies | >291 publications with INS and Kidney |
| Nerve Antibodies | >290 publications with INS and Nerve |
| Vascular Antibodies | >288 publications with INS and Vascular |
| Bone Antibodies | >169 publications with INS and Bone |


